The evidence also revealed that high-expression of FOXD3 could suppress proliferation, invasion and migration of CRC cells, and this effect could be reversed by miR-133a downregulation (P<0.05) (Figure 5D-F). The gene discussed is FOXD3; the disease is colorectal carcinoma.